Patent details

EP2445339 Title: DIFFUSION ENHANCING COMPOUND AND ITS USE WITH A THROMBOLYTIC

Basic Information

Publication number:
EP2445339
PCT Application Number:
US2010001794
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP107924441
PCT Publication Number:
WO2010151314
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DIFFUSION ENHANCING COMPOUND AND ITS USE WITH A THROMBOLYTIC
French Title of Invention:
COMPOSÉ AMÉLIORANT LA DIFFUSION ET SON UTILISATION AVEC UN THROMBOLYTIQUE
German Title of Invention:
VERTEILUNGSVERBESSERNDE VERBINDUNG UND IHRE VERWENDUNG MIT EINEM THROMBOLYTIKUM
SPC Number:

Dates

Filing date:
22/06/2010
Grant date:
07/08/2019
EP Publication Date:
02/05/2012
PCT Publication Date:
29/12/2010
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/08/2019
EP B1 Publication Date:
07/08/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/06/2020
Expiration date:
22/06/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/07/2019
 
 

Name:
Diffusion Pharmaceuticals LLC
Address:
1317 Carlton Avenue, Suite 200, Charlottesville, Virginia 22902, United States (US)

Inventor

Name:
GAINER, John, L.
Address:
United States (US)

Priority

Priority Number:
213575 P
Priority Date:
22/06/2009
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/203; A61K 38/48; A61P 9/10;

Publication

European Patent Bulletin

Issue number:
201932
Publication date:
07/08/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages